We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current MD market cap is 1.22B. The company's latest EPS is USD -0.7034 and P/E is -36.35.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 506.61M | 496.44M | 495.1M | 504.3M | 511.16M |
| Operating Income | 40.93M | -111.01M | 16.41M | -157.26M | 34.27M |
| Net Income | 21.39M | -124.29M | 4.04M | -153.03M | 19.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.51B | 1.73B | 1.91B | 1.97B | 1.99B |
| Operating Income | -1.13B | 99.72M | 197.55M | 174.41M | 9.38M |
| Net Income | -1.5B | -796.49M | 130.96M | 66.34M | -60.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.33B | 2.22B | 2.17B | 2B | 2.08B |
| Total Liabilities | 1.36B | 1.37B | 1.31B | 1.29B | 1.34B |
| Total Equity | 967.99M | 849.06M | 856.2M | 706.46M | 732.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.15B | 3.35B | 2.72B | 2.35B | 2.22B |
| Total Liabilities | 2.65B | 2.6B | 1.83B | 1.46B | 1.37B |
| Total Equity | 1.5B | 747.72M | 896.69M | 891.63M | 849.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 68.08M | 137.33M | -125.23M | -18.28M | 73.56M |
| Investing | -35.75M | -48.18M | -16.24M | -29.13M | -33.47M |
| Financing | -20.97M | -25.72M | 76.2M | -6.45M | -9.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 346.64M | 204.62M | 76.74M | 166.94M | 137.33M |
| Investing | 102.46M | 815.51M | -53.07M | -56.95M | -48.18M |
| Financing | -393.07M | -4.16M | -760.12M | -487.55M | -25.72M |
| Market Cap | 1.22B |
| Price to Earnings Ratio | -36.35 |
| Price to Sales Ratio | 1.1 |
| Price to Cash Ratio | 29.98 |
| Price to Book Ratio | 2.59 |
| Dividend Yield | - |
| Shares Outstanding | 85.88M |
| Average Volume (1 week) | 625.8k |
| Average Volume (1 Month) | 741.31k |
| 52 Week Change | 55.84% |
| 52 Week High | 16.30 |
| 52 Week Low | 6.62 |
| Spread (Intraday) | 3.82 (21.58%) |
| Company Name | Pediatrix Medical Group Inc |
| Address |
1301 concord terrace sunrise, florida 33323 |
| Website | https://www.mednax.com |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
